Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

V Odlind

Showing results (11-20 of 89) with videos related to

Pageof 9
Sort By:
International Journal of Gynaecology and Obstetrics: the Official Organ of the International Federation of Gynaecology and Obstetrics|January 1, 1987
The passage of exogenous hormones into breast milk--possible effectsE Johansson, V Odlind
Lakartidningen|May 26, 1998
[The SFOG prioritizes continuing education. The CME is introduced!]I Milsom, V Odlind
Lakartidningen|November 22, 1989
[Contradictory views at meeting of experts: support for the hypothesis on increased risk of breast cancer after prolonged use of oral contraceptives]V Odlind, I Persson
Lakartidningen|March 26, 1997
[P pills and APC resistance. General screening is not justified]I Milsom, V Odlind
Clinical Pharmacology and Therapeutics|April 5, 2012
Off-label drug use in pediatric patientsE Kimland, V Odlind
Lakartidningen|April 12, 1989
[Increasing number of abortions among young women--a medical or a social problem?]V Odlind, L Ruusuvaara
Contraception|October 1, 1988
The antiprogestational agent RU 486 as an abortifacient in early human pregnancy: a comparison of three dose regimensL Birgerson, V Odlind
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|January 1, 1991
Incidence of legal abortion in Sweden after the Chernobyl accidentV Odlind, A Ericson
Fertility and Sterility|October 1, 1987
Early pregnancy termination with antiprogestins: a comparative clinical study of RU 486 given in two dose regimens and EpostaneL Birgerson, V Odlind
Lakartidningen|December 11, 1996
[Ultrasound screening--quality assurance of the method is important]V Odlind, H Almström
Pageof 9

Showing results (11-20 of 89) with videos related to

Sort By:
Pageof 9
International Journal of Gynaecology and Obstetrics: the Official Organ of the International Federation of Gynaecology and Obstetrics|January 1, 1987
The passage of exogenous hormones into breast milk--possible effectsE Johansson, V Odlind
Lakartidningen|May 26, 1998
[The SFOG prioritizes continuing education. The CME is introduced!]I Milsom, V Odlind
Lakartidningen|November 22, 1989
[Contradictory views at meeting of experts: support for the hypothesis on increased risk of breast cancer after prolonged use of oral contraceptives]V Odlind, I Persson
Lakartidningen|March 26, 1997
[P pills and APC resistance. General screening is not justified]I Milsom, V Odlind
Clinical Pharmacology and Therapeutics|April 5, 2012
Off-label drug use in pediatric patientsE Kimland, V Odlind
Lakartidningen|April 12, 1989
[Increasing number of abortions among young women--a medical or a social problem?]V Odlind, L Ruusuvaara
Contraception|October 1, 1988
The antiprogestational agent RU 486 as an abortifacient in early human pregnancy: a comparison of three dose regimensL Birgerson, V Odlind
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|January 1, 1991
Incidence of legal abortion in Sweden after the Chernobyl accidentV Odlind, A Ericson
Fertility and Sterility|October 1, 1987
Early pregnancy termination with antiprogestins: a comparative clinical study of RU 486 given in two dose regimens and EpostaneL Birgerson, V Odlind
Lakartidningen|December 11, 1996
[Ultrasound screening--quality assurance of the method is important]V Odlind, H Almström
Pageof 9